BACKGROUND: Endogenous uveitis is a sight-threatening disease. In addition to corticosteroids, immunosuppressive agents are commonly used to treat patients with severe course. Immunosuppressive drugs act nonspecifically, rather than providing a specific interaction with the critical pathogenetic pathways of uveitis. Better knowledge of the basic mechanisms underlying uveitis and of the molecules that are important for regulating inflammation has helped to create new and more specific treatment approaches. Biological therapy for inflammatory diseases employs substances that interfere with specific molecules or pathways induced in the body during the inflammatory process. METHODS: This review gives an overview on molecules that play a critical role in the pathogenetic process of uveitis, as has been observed in patients or the respective animal models, and summarizes the current experience with biologicals for the treatment of uveitis refractive to conventional immunosuppressives.
BACKGROUND: Endogenous uveitis is a sight-threatening disease. In addition to corticosteroids, immunosuppressive agents are commonly used to treat patients with severe course. Immunosuppressive drugs act nonspecifically, rather than providing a specific interaction with the critical pathogenetic pathways of uveitis. Better knowledge of the basic mechanisms underlying uveitis and of the molecules that are important for regulating inflammation has helped to create new and more specific treatment approaches. Biological therapy for inflammatory diseases employs substances that interfere with specific molecules or pathways induced in the body during the inflammatory process. METHODS: This review gives an overview on molecules that play a critical role in the pathogenetic process of uveitis, as has been observed in patients or the respective animal models, and summarizes the current experience with biologicals for the treatment of uveitis refractive to conventional immunosuppressives.
Authors: P S Linsley; P M Wallace; J Johnson; M G Gibson; J L Greene; J A Ledbetter; C Singh; M A Tepper Journal: Science Date: 1992-08-07 Impact factor: 47.728
Authors: Alasdair J Coles; D Alastair S Compston; Krzysztof W Selmaj; Stephen L Lake; Susan Moran; David H Margolin; Kim Norris; P K Tandon Journal: N Engl J Med Date: 2008-10-23 Impact factor: 91.245
Authors: Samuel Kyei; George Asumeng Koffuor; Paul Ramkissoon; Elvis Ofori Ameyaw; Emmanuel Akomanin Asiamah Journal: Int J Ophthalmol Date: 2016-04-18 Impact factor: 1.779
Authors: Wei Cheng Liang; Jia Lin Ren; Qiu Xiao Yu; Jian Li; Tsz Kin Ng; Wai Kit Chu; Yong Jie Qin; Kai On Chu; Andrew V Schally; Chi Pui Pang; Sun On Chan Journal: Proc Natl Acad Sci U S A Date: 2020-03-02 Impact factor: 11.205
Authors: Salvador Mérida; María Sancho-Tello; Amparo Navea; Inmaculada Almansa; María Muriach; Francisco Bosch-Morell Journal: PLoS One Date: 2014-03-03 Impact factor: 3.240